# Kymera Therapeutics, Inc. (KYMR)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/KYMR/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 34.37M | $ -69.23M | $ -89.27M | $ 80.47M | $ 1.54B |
| 2025 | $ 40.14M | $ -318.85M | $ -239.94M | $ 82.25M | $ 1.58B |
| 2024 | $ 49.48M | $ -235.29M | $ -217.93M | $ 87.76M | $ 835.62M |
| 2023 | $ 84.98M | $ -158.90M | $ -148.46M | $ 84.67M | $ 394.97M |
| 2022 | $ 52.31M | $ -172.94M | $ -174.18M | $ 17.34M | $ 490.15M |
| 2021 | $ 86.57M | $ -119.12M | $ -155.17M | $ 17.96M | $ 459.64M |
| 2020 | $ 43.36M | $ -58.08M | $ 100.68M | $ 17.99M | $ 283.89M |
| 2019 | $ 3.59M | $ -29.60M | $ -30.57M | $ 21.19M | $ -74.41M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.05 |
| Liabilities / Eq | 0.08 |
| Current Ratio | 10.81 |

## Other views

- [Metrics](https://sponda.capital/en/KYMR.md)
- [Charts](https://sponda.capital/en/KYMR/charts.md)
- [Compare](https://sponda.capital/en/KYMR/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.